The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-14 of 14 articles
Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis
Xhepa E,
Bresha J,
Joner M,
Hapfelmeier A,
Rivero F,
Ndrepepa G,
Nano N,
Cuesta J,
Kufner S,
Cassese S,
Bastante T,
Aytekin A,
Rroku A,
García-Guimaraes M,
Lahmann A,
Pinieck S,
Rai H,
Fusaro M,
Schunkert H,
Pérez-Vizcayno M,
Gonzalo N,
Alfonso F,
Kastrati A
August 6, 2021 | 10.4244/EIJ-D-20-00662
Obesity paradox after percutaneous coronary intervention - closing in on the truth behind the phenomenon
January 17, 2020 | 10.4244/EIJV15I13A208
No-reflow after percutaneous coronary intervention: a correlate of poor outcome in both persistent and transient forms
June 20, 2018 | 10.4244/EIJV14I2A21
Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials
Cassese S,
Ndrepepa G,
Byrne R,
Kufner S,
Lahmann A,
Mankerious N,
Xhepa E,
Laugwitz K,
Schunkert H,
Fusaro M,
Kastrati A,
Joner M
June 20, 2018 | 10.4244/EIJ-D-18-00024
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials
Cassese S,
Byrne R,
Jüni P,
Wykrzykowska J,
Puricel S,
Ndrepepa G,
Schunkert H,
Fusaro M,
Cook S,
Kimura T,
Henriques J,
Serruys P,
Windecker S,
Kastrati A
January 19, 2018 | 10.4244/EIJ-D-17-00492
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials
Cassese S,
Ndrepepa G,
Byrne R,
Kufner S,
Xhepa E,
De Waha A,
Rheude T,
Colleran R,
Giacoppo D,
Harada Y,
Laugwitz K,
Schunkert H,
Fusaro M,
Kastrati A
October 20, 2017 | 10.4244/EIJ-D-16-00871
Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI
June 20, 2016 | 10.4244/EIJV12I3A52
Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention
Fiedler A,
Ndrepepa G,
Schulz S,
Floh S,
Hoppmann P,
Kufner S,
Bernlochner I,
Byrne R,
Schunkert H,
Laugwitz K,
Kastrati A
February 12, 2016 | 10.4244/EIJV11I11A249
Latest news
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
AHEAD OF PRINT
Antithrombotic strategy selection using smartphone technology
FREE ARTICLE - Jaya Chandrasekhar et al
June 3, 2022
AHEAD OF PRINT
The fingerprints of plaque rupture healing as detected by serial OCT imaging
FREE ARTICLE - Rocco Vergallo et al
June 2, 2022